Showing results (1-10 of 353) with videos related to
Sort By:
Pageof 36
International Immunology|November 4, 2000
CD4+ T lymphocytes as a primary cellular target for BAT mAb stimulationA Raiter, G Rodionov, A Novogrodsky, et al.Immunology Letters|September 11, 1999
Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cellsA Raiter, A Novogrodsky, B HardyProceedings of the National Academy of Sciences of the United States of America|May 27, 1997
A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient miceB Hardy, R Kovjazin, A Raiter, et al.Human Antibodies|January 1, 1997
Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative studyB Hardy, R Kovjazin, A Raiter, et al.International Journal of Oncology|October 18, 2001
Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphomaB Hardy, L Indjiia, G Rodionov, et al.Cellular Immunology|January 1, 1989
A monoclonal antibody to human B lymphoblastoid cells activates human and murine T lymphocytesB Hardy, D Dotan, A NovogrodskyCancer Immunology, Immunotherapy : CII|June 1, 1995
Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding proteinB Hardy, M Galli, E Rivlin, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 29, 2016
Peptide Binding Glucose Regulated Protein 78 Improves Type 1 Diabetes by Preventing Pancreatic β Cell ApoptosisA Raiter, A Tenenbaum, M Yackobovitch-Gavan, et al.Cancer Research|November 15, 1994
A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in miceB Hardy, I Yampolski, R Kovjazin, et al.Head & Neck|May 22, 2001
Effect of exogenous thyroid-stimulating hormone on thyroid papillary carcinoma cells in tissue cultureM Chaimoff, A Raiter, S Avidan, et al.Pageof 36